基础胰岛素与预混胰岛素联合口服降糖药治疗2型糖尿病临床疗效比较

许英, 沈红丽, 徐松梅

许英, 沈红丽, 徐松梅. 基础胰岛素与预混胰岛素联合口服降糖药治疗2型糖尿病临床疗效比较[J]. 实用临床医药杂志, 2013, (7): 85-87. DOI: 10.7619/jcmp.201307028
引用本文: 许英, 沈红丽, 徐松梅. 基础胰岛素与预混胰岛素联合口服降糖药治疗2型糖尿病临床疗效比较[J]. 实用临床医药杂志, 2013, (7): 85-87. DOI: 10.7619/jcmp.201307028
XU Ying, SHEN Hongli, XU Songhai. Comparison on the application of basal insulin and premixed insulin respectively combined with oral hypoglycemic agents in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (7): 85-87. DOI: 10.7619/jcmp.201307028
Citation: XU Ying, SHEN Hongli, XU Songhai. Comparison on the application of basal insulin and premixed insulin respectively combined with oral hypoglycemic agents in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (7): 85-87. DOI: 10.7619/jcmp.201307028

基础胰岛素与预混胰岛素联合口服降糖药治疗2型糖尿病临床疗效比较

详细信息
  • 中图分类号: R587.1

Comparison on the application of basal insulin and premixed insulin respectively combined with oral hypoglycemic agents in patients with type 2 diabetes mellitus

  • 摘要: 目的 探讨基础胰岛素与预混胰岛素联合口服降糖药在2型糖尿病患者的临床疗效.方法 将42例2型糖尿病患者随机分为联合基础胰岛素治疗组和联合预混胰岛素对照组,每组21例.2组患者均给予常规治疗,口服降糖药物、调节血脂、控制饮食和体质量.联合基础胰岛素治疗组在常规治疗基础上皮下注射基础胰岛素.联合预混胰岛素对照组在常规治疗基础上皮下注射预混胰岛素(30R).检测治疗前后空腹血糖(FBG)、餐后2h血糖(2hPG)水平,高压液相法测定HbAlc(糖化血红蛋白)水平.比较2组胰岛素注射剂量,观察血糖达标和低血糖事件发生情况.结果 与治疗前比较,2组治疗后FBG、2hPG、HbAlc水平均明显降低,联合基础胰岛素治疗组降低的更加明显.联合基础胰岛素治疗组胰岛素用量显著少于联合预混胰岛素对照组.2组患者治疗过程中出现低血糖事件均为轻度,进食后可缓解.结论基础胰岛素联合口服降糖药控制FPG、HbAlc效果较好,胰岛素用量较少.
  • Raccah D, Haak T J, Huet D. Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes:results of the OSIRIS study [J]. Diabetes & Metabolism, 2012(6):507.
    Abrahamson M J, Peters A. Intensification of insulin therapy in patients with type 2 diabetes mellitus:an algorithm for basal-bolus therapy [J]. Annals of Medicine, 2012(8):836.
    Barnett A H. The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus:guidance from studies of liraglutide [J]. Diabetes, Obesity and Metabolism, 2012(4):304.
    Gao G Q, Dong Q Y, Li S J. Investigation of the insulin dose and characteristics of continuous subcutaneous insulin infusion in Chinese people with type 2 diabetes [J]. Diabetes Technology and Therapeutics, 2011, (11):1135.
    Zeng L, Lu H, Deng H. Noninferiority effects on glycemic control and β-cell function improvement in newly diagnosed type 2 diabetes patients:basal insulin monotherapy versus continuous subcutaneous insulin infusion treatment [J]. Diabetes Technology and Therapeutics, 2012(1):35.
    Koivisto V, Cleall S, Pontiroli A E. Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients:a prospective randomized open-label trial [J]. Diabetes, Obesity and Metabolism, 2011, (12):1149.
    Blevins T. Control of postprandial glucose levels with insulin in type2 diabetes [J]. Postgraduate Medicine, 2011(4):135.
    Martorella A J. Iatrogenic hypoglycemia in patients with type 2 diabetes:comparison of insulin analog premixes and human insulin premixes [J]. Postgraduate Medicine, 2011(4):7.
    杨俏玲, 黄建宁, 杨瑞英. OAD联合甘精胰岛素与预混胰岛素治疗2型糖尿病的疗效比较 [J]. 宁夏医科大学学报, 2009(5):681.doi: 10.3969/j.issn.1674-6309.2009.05.064.
    秦利. 预混胰岛素与口服降糖药联合基础胰岛素治疗2型糖尿病的疗效和安全性比较 [J]. 医学临床研究, 2012(6):1054.doi: 10.3969/j.issn.1671-7171.2012.06.018.
计量
  • 文章访问数:  148
  • HTML全文浏览量:  28
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 发布日期:  2013-06-12

目录

    /

    返回文章
    返回
    x 关闭 永久关闭